Elizabeth Warren Wants the Federal Government to Encourage Research on Pot’s Medical Benefits

<a href="http://www.warren.senate.gov/?p=photos">Senate.gov</a> (Elizabeth Warren);<a href="http://www.shutterstock.com/cat.mhtml?lang=en&language=en&ref_site=photo&search_source=search_form&version=llv1&anyorall=all&safesearch=1&use_local_boost=1&autocomplete_id=&searchterm=medical%20marijuana&show_color_wheel=1&orient=&commercial_ok=&media_type=images&search_cat=&searchtermx=&photographer_name=&people_gender=&people_age=&people_ethnicity=&people_number=&color=&page=1&inline=231863464">Shutterstock/Biro Emoke </a> (green cross)

For indispensable reporting on the coronavirus crisis and more, subscribe to Mother Jones' newsletters.


On Monday, Sen. Elizabeth Warren wrote a letter to top federal drug enforcement and health officials requesting that they do more to conduct and facilitate research on the health benefits of marijuana. Among other things, she urged the government to end its monopoly on the supply of pot for research purposes, coordinate large-scale epidemiological studies on marijuana use, and assure scientists that their work on pot won’t jeopardize their other federal research funding.

“While the federal government has emphasized research on the potential harms associated with the use of marijuana,” says the letter, which was signed by Warren and seven other Democratic senators, “there is still very limited research on the potential health benefits of marijuana—despite the fact that millions of Americans are now eligible by state law to use the drug for medical purposes.”

Last month, the Department of Health and Human Services made a widely publicized move to streamline the approval of medical-marijuana studies, but Warren argues that this should be just the start of a broader effort to legitimize and institutionalize research into the benefits of pot. Her letter urges HHS to conduct its own clinical trials and facilitate communication among the 23 states that have legalized pot as medicine “in order to derive a more accurate picture of marijuana use and treatments across the country.”

The senators also appear eager to see the government reevaluate marijuana’s listing under Schedule I of the Controlled Substances Act, a category reserved for drugs, including heroin and LSD, that have “no currently accepted medical use.” They ask for a timeline for analyzing existing pot research and making a recommendation for re-scheduling the drug. Their letter also asks whether the analysis will include comparisons with tobacco and alcohol.

Thank you!

We didn't know what to expect when we told you we needed to raise $400,000 before our fiscal year closed on June 30, and we're thrilled to report that our incredible community of readers contributed some $415,000 to help us keep charging as hard as we can during this crazy year.

You just sent an incredible message: that quality journalism doesn't have to answer to advertisers, billionaires, or hedge funds; that newsrooms can eke out an existence thanks primarily to the generosity of its readers. That's so powerful. Especially during what's been called a "media extinction event" when those looking to make a profit from the news pull back, the Mother Jones community steps in.

The months and years ahead won't be easy. Far from it. But there's no one we'd rather face the big challenges with than you, our committed and passionate readers, and our team of fearless reporters who show up every day.

Thank you!

We didn't know what to expect when we told you we needed to raise $400,000 before our fiscal year closed on June 30, and we're thrilled to report that our incredible community of readers contributed some $415,000 to help us keep charging as hard as we can during this crazy year.

You just sent an incredible message: that quality journalism doesn't have to answer to advertisers, billionaires, or hedge funds; that newsrooms can eke out an existence thanks primarily to the generosity of its readers. That's so powerful. Especially during what's been called a "media extinction event" when those looking to make a profit from the news pull back, the Mother Jones community steps in.

The months and years ahead won't be easy. Far from it. But there's no one we'd rather face the big challenges with than you, our committed and passionate readers, and our team of fearless reporters who show up every day.

We Recommend

Latest

Sign up for our newsletters

Subscribe and we'll send Mother Jones straight to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate

We have a new comment system! We are now using Coral, from Vox Media, for comments on all new articles. We'd love your feedback.